Delivery Order SPE2DB20D3101-SPE2DB25FRMD0
Award Date 6/3/25
Potential Completion Date 6/4/25
Potential Value $1.4K
Federal Agency
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $1,480.15 on November 17, 2025, for the supply of Xyosted 75 mg/0.5 mL auto-injector units. This non-set-aside, competitively awarded contract represents a firm fixed-price delivery order with an ultimate completion date of November 18, 2025, and will be performed at the company's corporate office location in Conshohocken, Pennsylvania. Xyosted is a testosterone replacement therapy administered via...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $6,850.37 for the supply of Xyosted 100 mg/0.5 mL auto-injector units on August 27, 2025. This is a firm fixed price, competitively awarded contract with no set-aside designation. The award was completed with an ultimate completion date of August 28, 2025, and will be performed at the vendor's Corporate Office location in Conshohocken, Pennsylvania. Xyosted is a testosterone replacement therapy medication...
- The Defense Logistics Agency awarded a $1,752.22 delivery order to AmerisourceBergen Drug Corp for Xyosted 50 mg/0.5 mL auto-injectors on September 5, 2025, with completion scheduled for September 8, 2025. This firm fixed-price delivery order represents a competitively awarded, non-set-aside contract and will be performed at the contractor's Conshohocken, Pennsylvania facility. Xyosted is a testosterone replacement therapy medication delivered via auto-injector, reflecting the Defense...
- The Defense Logistics Agency awarded a delivery order valued at $1,248.08 to AmerisourceBergen Drug Corp for Xyosted 100 mg/0.5 mL auto-injectors on August 22, 2025, with completion targeted for August 25, 2025. This firm fixed-price contract represents a non-set-aside competitive award and will be fulfilled at the contractor's corporate office location in Conshohocken, Pennsylvania. Xyosted is a testosterone replacement therapy product delivered via auto-injector, addressing pharmaceutical...
- The Defense Logistics Agency awarded a $1,317.52 delivery order to AmerisourceBergen Drug Corp on June 18, 2025, for Xyosted 50 mg/0.5 mL auto-injector units with a completion date of June 20, 2025. This competitively awarded, firm fixed-price contract contains no set-aside designation and is to be performed at the contractor's Corporate Office location in Conshohocken, Pennsylvania. Xyosted is a testosterone replacement therapy product delivered via auto-injector, supporting the agency's...
- The Defense Logistics Agency awarded a delivery order valued at $6,026.75 to AmerisourceBergen Drug Corp for the supply of Xyosted 100 mg/0.5 mL auto-injectors on December 3, 2025, with completion scheduled for December 4, 2025. This firm fixed-price delivery order, which was competitively awarded with no set-aside designation, will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. Xyosted is a testosterone replacement therapy product supplied in auto-injector...
- The Defense Logistics Agency awarded a $2,205.54 delivery order to AmerisourceBergen Drug Corp for Xyosted 75 mg/0.5 mL auto-injectors on August 13, 2025, with completion targeted for August 14, 2025. This competitively awarded, firm fixed-price contract involves no set-aside designation and will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. Xyosted is a testosterone replacement therapy product delivered via auto-injection, representing part of the...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for $1,544.96 to supply Xyosted 50 mg/0.5 mL auto-injector units. The contract, awarded on June 2, 2025, with an ultimate completion date of June 3, 2025, represents a firm fixed-price delivery order with no set-aside designation. Performance will occur at the vendor's corporate office location in Conshohocken, Pennsylvania. Xyosted is a testosterone replacement therapy auto-injector prescribed for hormone...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,646.02 to AmerisourceBergen Drug Corp for the supply of Xyosted 100 mg/0.5 mL auto-injector units on July 25, 2025, with completion scheduled for July 28, 2025. This firm fixed-price delivery order was issued without a set-aside designation and represents a competitive award under open competition. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. Xyosted is a...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $1,807.85 for Xyosted 75 mg/0.5 mL auto-injector units on December 8, 2025, with completion scheduled for December 9, 2025. This competitively awarded, firm fixed-price contract is non-set-aside and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a procurement of this injectable testosterone replacement therapy medication for...